These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35043730)

  • 1. Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs.
    Ricci G; Busardò FP; Gibelli F; Sirignano A; Brunetti P
    Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1445-1454. PubMed ID: 35043730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recreational use of GHB and prescribed drugs: the challenge in forensic and clinical toxicology.
    Brunetti P; Umani Ronchi F
    Clin Ter; 2021 Sep; 172(5):423-424. PubMed ID: 34625772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes.
    Busardò FP; Jones AW
    Clin Toxicol (Phila); 2019 Mar; 57(3):149-163. PubMed ID: 30307336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review.
    Amsterdam JV; Brunt TM; Pereira FR; Crunelle CL; Brink WVD
    Curr Neuropharmacol; 2022; 20(4):809-819. PubMed ID: 34151766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.
    Marinelli E; Beck R; Malvasi A; Lo Faro AF; Zaami S
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):19-26. PubMed ID: 32597141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review.
    Dufayet L; Bargel S; Bonnet A; Boukerma AK; Chevallier C; Evrard M; Guillotin S; Loeuillet E; Paradis C; Pouget AM; Reynoard J; Vaucel JA
    Regul Toxicol Pharmacol; 2023 Aug; 142():105435. PubMed ID: 37343712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.
    Felmlee MA; Morse BL; Morris ME
    AAPS J; 2021 Jan; 23(1):22. PubMed ID: 33417072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GHB concentration in a related post-mortem case.
    Mortali C; Berretta P
    Clin Ter; 2020; 171(3):e235-e236. PubMed ID: 32323711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.
    Keating GM
    Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
    J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma hydroxy butyrate abuse and dependency.
    Gonzalez A; Nutt DJ
    J Psychopharmacol; 2005 Mar; 19(2):195-204. PubMed ID: 15871147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
    Busardò FP; Gottardi M; Tini A; Minutillo A; Sirignano A; Marinelli E; Zaami S
    Curr Drug Metab; 2018; 19(13):1080-1085. PubMed ID: 30251602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.